By Helgi Library - May 22, 2023
Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 1...
By Helgi Library - May 22, 2023
Shop Apotheke Europe stock traded at EUR 41.8 per share at the end 2022 translating into a market capitalization of USD 885 mil. ...
By Helgi Library - May 22, 2023
Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, ...
| Profit Statement | 2028 | 2029 | 2030 | |
| Sales | EUR mil | 3,461 | 3,775 | 4,098 |
| Gross Profit | EUR mil | 920 | 1,004 | 1,090 |
| EBITDA | EUR mil | 207 | 249 | 275 |
| EBIT | EUR mil | 181 | 211 | 243 |
| Financing Cost | EUR mil | 33.8 | 37.0 | 42.5 |
| Pre-Tax Profit | EUR mil | 147 | 174 | 200 |
| Net Profit | EUR mil | 113 | 136 | 152 |
| Dividends | EUR mil | 0 | 0 | 0 |
| Balance Sheet | 2028 | 2029 | 2030 | |
| Total Assets | EUR mil | 1,437 | 1,545 | 1,662 |
| Non-Current Assets | EUR mil | 770 | 846 | 930 |
| Current Assets | EUR mil | 666 | 699 | 732 |
| Working Capital | EUR mil | 104 | 113 | 123 |
| Shareholders' Equity | EUR mil | 649 | 784 | 936 |
| Liabilities | EUR mil | 788 | 761 | 726 |
| Total Debt | EUR mil | 513 | 461 | 402 |
| Net Debt | EUR mil | 210 | 158 | 97.4 |
| Ratios | 2028 | 2029 | 2030 | |
| ROE | % | 19.0 | 18.9 | 17.7 |
| ROCE | % | 13.5 | 14.8 | 15.1 |
| Gross Margin | % | 26.6 | 26.6 | 26.6 |
| EBITDA Margin | % | 5.99 | 6.60 | 6.72 |
| EBIT Margin | % | 5.22 | 5.58 | 5.92 |
| Net Margin | % | 3.25 | 3.60 | 3.71 |
| Net Debt/EBITDA | 1.01 | 0.635 | 0.354 | |
| Net Debt/Equity | % | 32.4 | 20.2 | 10.4 |
| Cost of Financing | % | 6.37 | 7.60 | 9.85 |
| Valuation | 2028 | 2029 | 2030 | |
| Market Capitalisation | USD mil | 1,947 | 1,947 | 1,947 |
| Enterprise Value (EV) | USD mil | 2,194 | 2,132 | 2,061 |
| Number Of Shares | mil | 18.1 | 18.1 | 18.1 |
| Share Price | EUR | 91.9 | 91.9 | 91.9 |
| EV/EBITDA | 9.02 | 7.30 | 6.38 | |
| EV/Sales | 0.540 | 0.482 | 0.429 | |
| Price/Earnings (P/E) | 14.7 | 12.2 | 10.9 | |
| Price/Book Value (P/BV) | 2.56 | 2.12 | 1.77 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | |||||||||||||||||||||||
| Sales | EUR mil | ... | ... | ... | ... | 284 | 540 | 701 | 968 | 1,060 | |||||||||||||
| Gross Profit | EUR mil | ... | ... | ... | ... | 57.6 | 99.3 | 138 | 220 | 267 | |||||||||||||
| EBIT | EUR mil | ... | ... | ... | ... | -19.2 | -28.7 | -33.4 | -0.866 | -65.7 | |||||||||||||
| Net Profit | EUR mil | ... | ... | ... | ... | -21.4 | -33.6 | -36.3 | -16.8 | -74.2 | |||||||||||||
| ROE | % | ... | ... | ... | ... | ... | -12.9 | -14.8 | -16.2 | -5.10 | -17.7 | ||||||||||||
| EBIT Margin | % | ... | ... | ... | ... | -6.76 | -5.32 | -4.77 | -0.089 | -6.20 | |||||||||||||
| Net Margin | % | ... | ... | ... | ... | -7.52 | -6.23 | -5.17 | -1.73 | -7.00 | |||||||||||||
| Employees | ... | ... | ... | ... | 483 | 843 | 1,011 | 1,220 | 1,569 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||||
| balance sheet | |||||||||||||||||||||||
| Total Assets | EUR mil | ... | ... | ... | ... | 298 | 350 | 428 | 537 | 783 | |||||||||||||
| Non-Current Assets | EUR mil | ... | ... | ... | ... | 202 | 214 | 217 | 283 | 350 | |||||||||||||
| Current Assets | EUR mil | ... | ... | ... | ... | 95.4 | 136 | 211 | 254 | 433 | |||||||||||||
| Shareholders' Equity | EUR mil | ... | ... | ... | ... | 239 | 214 | 233 | 425 | 415 | |||||||||||||
| Liabilities | EUR mil | ... | ... | ... | ... | 58.8 | 136 | 195 | 112 | 368 | |||||||||||||
| Non-Current Liabilities | EUR mil | 17.4 | 83.3 | 135 | 37.2 | 244 | |||||||||||||||||
| Current Liabilities | EUR mil | ... | ... | ... | ... | 41.5 | 52.7 | 59.8 | 74.6 | 124 | |||||||||||||
| Net Debt/EBITDA | ... | ... | ... | ... | 1.93 | -1.92 | -1.94 | -5.92 | 1.22 | ||||||||||||||
| Net Debt/Equity | % | ... | ... | ... | ... | -9.80 | 14.0 | 15.5 | -21.2 | -11.4 | |||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 90.5 | 13.3 | 8.55 | 11.5 | 6.24 | |||||||||
| cash flow | |||||||||||||||||||||||
| Total Cash From Operations | EUR mil | ... | ... | ... | ... | -25.3 | -18.2 | -36.4 | 4.88 | 5.29 | |||||||||||||
| Total Cash From Investing | EUR mil | ... | ... | ... | ... | -0.858 | -38.6 | -33.4 | -40.3 | -84.3 | |||||||||||||
| Total Cash From Financing | EUR mil | ... | ... | ... | ... | -1.42 | 70.2 | 108 | 63.2 | 236 | |||||||||||||
| Net Change In Cash | EUR mil | ... | ... | ... | ... | -27.6 | 13.4 | 38.3 | 27.8 | 157 | |||||||||||||
| valuation | |||||||||||||||||||||||
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 670 | 519 | 638 | 3,203 | 2,304 | ||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 642 | 553 | 678 | 3,093 | 2,250 | ||||||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 9.50 | 12.0 | 13.1 | 14.4 | 17.9 | ||||||||||
| Share Price | EUR | ... | ... | ... | ... | ... | ... | ... | 46.4 | 37.6 | 43.5 | 148 | 113 | ||||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | -20.6 | -13.5 | -15.6 | -127 | -27.3 | |||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | -23.3 | -15.1 | -26.5 | -195 | -32.3 | |||||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | -47.1 | -30.3 | -32.2 | 174 | -48.5 | |||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.84 | 2.12 | 2.44 | 5.01 | 4.88 | |||||||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 |
| income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| income statement | |||||||||||||||||||||||
| Sales | EUR mil | ... | ... | ... | ... | 284 | 540 | 701 | 968 | 1,060 | |||||||||||||
| Cost of Goods & Services | EUR mil | ... | ... | ... | ... | 226 | 440 | 563 | 749 | 794 | |||||||||||||
| Gross Profit | EUR mil | ... | ... | ... | ... | 57.6 | 99.3 | 138 | 220 | 267 | |||||||||||||
| Selling, General & Admin | EUR mil | ... | ... | ... | ... | 79.8 | 128 | 172 | 204 | 305 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Research & Development | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Other Operating Expense | EUR mil | ... | ... | ... | ... | ... | ... | ... | 0.002 | 0.002 | 0.001 | 0 | 0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Staff Cost | EUR mil | ... | ... | ... | ... | 20.0 | 40.0 | 54.1 | 66.9 | 120 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Other Operating Cost (Income) | EUR mil | ... | ... | ... | ... | 3.02 | 0.196 | 0.736 | 0.065 | 0.160 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| EBITDA | EUR mil | ... | ... | ... | ... | -12.1 | -15.6 | -18.6 | 15.2 | -38.7 | |||||||||||||
| Depreciation | EUR mil | ... | ... | ... | ... | 2.49 | 3.62 | 14.9 | 5.82 | 11.4 | |||||||||||||
| EBIT | EUR mil | ... | ... | ... | ... | -19.2 | -28.7 | -33.4 | -0.866 | -65.7 | |||||||||||||
| Net Financing Cost | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | 2.20 | 5.90 | 8.84 | 10.8 | 8.57 | |||||||||
| Financing Cost | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | 2.20 | 6.20 | 10.2 | 10.8 | 8.57 | |||||||||
| Financing Income | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0.300 | 1.33 | 0 | 0 | |||||||||
| FX (Gain) Loss | EUR mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0.234 | -1.49 | ||||||||||
| (Income) / Loss from Affiliates | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -0.104 | -0.045 | 0.427 | |||||||||
| Extraordinary Cost | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Pre-Tax Profit | EUR mil | ... | ... | ... | ... | -21.4 | -34.6 | -42.2 | -15.9 | -77.9 | |||||||||||||
| Tax | EUR mil | ... | ... | ... | ... | -0.045 | -0.982 | -5.91 | 0.839 | -3.70 | |||||||||||||
| Minorities | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Net Profit | EUR mil | ... | ... | ... | ... | -21.4 | -33.6 | -36.3 | -16.8 | -74.2 | |||||||||||||
| Net Profit Avail. to Common | EUR mil | ... | ... | ... | ... | -21.4 | -33.6 | -36.3 | -16.8 | -74.2 | |||||||||||||
| Dividends | EUR mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| growth rates | |||||||||||||||||||||||
| Total Revenue Growth | % | ... | ... | ... | ... | ... | 60.1 | 90.0 | 29.9 | 38.1 | 9.53 | ||||||||||||
| Operating Cost Growth | % | ... | ... | ... | ... | ... | 59.2 | 60.7 | 34.0 | 28.3 | 50.8 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| Staff Cost Growth | % | ... | ... | ... | ... | ... | 47.6 | 99.9 | 35.3 | 23.8 | 78.8 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| EBITDA Growth | % | ... | ... | ... | ... | ... | 45.1 | 28.2 | 19.4 | -182 | -355 | ||||||||||||
| EBIT Growth | % | ... | ... | ... | ... | ... | 64.9 | 49.7 | 16.4 | -97.4 | 7,486 | ||||||||||||
| Pre-Tax Profit Growth | % | ... | ... | ... | ... | ... | 2.11 | 61.6 | 21.9 | -62.2 | 389 | ||||||||||||
| Net Profit Growth | % | ... | ... | ... | ... | ... | 15.8 | 57.4 | 7.92 | -53.8 | 342 | ||||||||||||
| ratios | |||||||||||||||||||||||
| ROE | % | ... | ... | ... | ... | ... | -12.9 | -14.8 | -16.2 | -5.10 | -17.7 | ||||||||||||
| ROA | % | ... | ... | ... | ... | ... | -10.2 | -10.4 | -9.33 | -3.48 | -11.2 | ||||||||||||
| ROCE | % | ... | ... | ... | ... | ... | -15.3 | -13.6 | -13.9 | -5.48 | -20.1 | ||||||||||||
| Gross Margin | % | ... | ... | ... | ... | 20.3 | 18.4 | 19.6 | 22.7 | 25.1 | |||||||||||||
| EBITDA Margin | % | ... | ... | ... | ... | -4.27 | -2.88 | -2.65 | 1.57 | -3.65 | |||||||||||||
| EBIT Margin | % | ... | ... | ... | ... | -6.76 | -5.32 | -4.77 | -0.089 | -6.20 | |||||||||||||
| Net Margin | % | ... | ... | ... | ... | -7.52 | -6.23 | -5.17 | -1.73 | -7.00 | |||||||||||||
| Payout Ratio | % | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 90.5 | 13.3 | 8.55 | 11.5 | 6.24 | |||||||||
| Net Debt/EBITDA | ... | ... | ... | ... | 1.93 | -1.92 | -1.94 | -5.92 | 1.22 |
| balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| balance sheet | |||||||||||||||||||||||
| Cash & Cash Equivalents | EUR mil | ... | ... | ... | ... | ... | ... | ... | 28.3 | 58.8 | 113 | 128 | 284 | ||||||||||
| Receivables | EUR mil | ... | ... | ... | ... | 20.5 | 22.1 | 26.7 | 30.0 | 27.9 | |||||||||||||
| Inventories | EUR mil | ... | ... | ... | ... | 40.0 | 43.3 | 56.7 | 81.2 | 96.6 | |||||||||||||
| Other ST Assets | EUR mil | ... | ... | ... | ... | 6.52 | 11.5 | 14.2 | 14.6 | 24.4 | |||||||||||||
| Current Assets | EUR mil | ... | ... | ... | ... | 95.4 | 136 | 211 | 254 | 433 | |||||||||||||
| Property, Plant & Equipment | EUR mil | ... | ... | ... | ... | 8.28 | 11.9 | 13.2 | 74.5 | 78.3 | |||||||||||||
| LT Investments & Receivables | EUR mil | ... | ... | ... | ... | 0 | 0 | 2.50 | 1.74 | 13.1 | |||||||||||||
| Intangible Assets | EUR mil | ... | ... | ... | ... | 190 | 200 | 200 | 205 | 257 | |||||||||||||
| Goodwill | EUR mil | ... | ... | ... | ... | 126 | 129 | 129 | 129 | 153 | |||||||||||||
| Non-Current Assets | EUR mil | ... | ... | ... | ... | 202 | 214 | 217 | 283 | 350 | |||||||||||||
| Total Assets | EUR mil | ... | ... | ... | ... | 298 | 350 | 428 | 537 | 783 | |||||||||||||
| Trade Payables | EUR mil | ... | ... | ... | ... | 23.1 | 26.1 | 31.4 | 51.3 | 78.1 | |||||||||||||
| Short-Term Debt | EUR mil | ... | ... | ... | ... | 4.86 | 16.3 | 17.7 | 5.42 | 6.41 | |||||||||||||
| Other ST Liabilities | EUR mil | ... | ... | ... | ... | 7.31 | 7.93 | 10.1 | 8.32 | 15.1 | |||||||||||||
| Current Liabilities | EUR mil | ... | ... | ... | ... | 41.5 | 52.7 | 59.8 | 74.6 | 124 | |||||||||||||
| Long-Term Debt | EUR mil | ... | ... | ... | ... | 0 | 72.4 | 132 | 32.8 | 230 | |||||||||||||
| Other LT Liabilities | EUR mil | ... | ... | ... | ... | 17.4 | 10.8 | 3.90 | 4.35 | 13.6 | |||||||||||||
| Non-Current Liabilities | EUR mil | 17.4 | 83.3 | 135 | 37.2 | 244 | |||||||||||||||||
| Liabilities | EUR mil | ... | ... | ... | ... | 58.8 | 136 | 195 | 112 | 368 | |||||||||||||
| Preferred Equity and Hybrid Capital | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Share Capital | EUR mil | ... | ... | ... | ... | ... | ... | ... | 289 | 292 | 341 | 552 | 567 | ||||||||||
| Treasury Stock | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Equity Before Minority Interest | EUR mil | ... | ... | ... | ... | 239 | 214 | 233 | 425 | 415 | |||||||||||||
| Minority Interest | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Equity | EUR mil | ... | ... | ... | ... | 239 | 214 | 233 | 425 | 415 | |||||||||||||
| growth rates | |||||||||||||||||||||||
| Total Asset Growth | % | ... | ... | ... | ... | ... | 147 | 17.5 | 22.3 | 25.5 | 45.8 | ||||||||||||
| Shareholders' Equity Growth | % | ... | ... | ... | ... | ... | 156 | -10.5 | 8.78 | 82.6 | -2.29 | ||||||||||||
| Net Debt Growth | % | ... | ... | ... | ... | ... | -59.9 | -228 | 20.1 | -350 | -47.4 | ||||||||||||
| Total Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 1,724 | 68.2 | -74.4 | 518 | |||||||||
| ratios | |||||||||||||||||||||||
| Total Debt | EUR mil | ... | ... | ... | ... | 4.86 | 88.7 | 149 | 38.2 | 236 | |||||||||||||
| Net Debt | EUR mil | ... | ... | ... | ... | -23.4 | 29.9 | 36.0 | -90.0 | -47.4 | |||||||||||||
| Working Capital | EUR mil | ... | ... | ... | ... | 37.4 | 39.3 | 52.0 | 59.9 | 46.4 | |||||||||||||
| Capital Employed | EUR mil | ... | ... | ... | ... | 240 | 254 | 269 | 343 | 397 | |||||||||||||
| Net Debt/Equity | % | ... | ... | ... | ... | -9.80 | 14.0 | 15.5 | -21.2 | -11.4 | |||||||||||||
| Current Ratio | ... | ... | ... | ... | 2.30 | 2.58 | 3.53 | 3.41 | 3.49 | ||||||||||||||
| Quick Ratio | ... | ... | ... | ... | ... | ... | ... | 1.18 | 1.53 | 2.34 | 2.12 | 2.51 |
| cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| cash flow | |||||||||||||||||||||||
| Net Profit | EUR mil | ... | ... | ... | ... | -21.4 | -33.6 | -36.3 | -16.8 | -74.2 | |||||||||||||
| Depreciation | EUR mil | ... | ... | ... | ... | 2.49 | 3.62 | 14.9 | 5.82 | 11.4 | |||||||||||||
| Non-Cash Items | EUR mil | ... | ... | ... | ... | -1.91 | 1.86 | -0.302 | 6.82 | 24.0 | |||||||||||||
| Change in Working Capital | EUR mil | ... | ... | ... | ... | -9.08 | 0.379 | -14.7 | -1.24 | 28.5 | |||||||||||||
| Total Cash From Operations | EUR mil | ... | ... | ... | ... | -25.3 | -18.2 | -36.4 | 4.88 | 5.29 | |||||||||||||
| Capital Expenditures | EUR mil | ... | ... | ... | ... | ... | ... | ... | -9.62 | -11.9 | -14.7 | -53.3 | -43.2 | ||||||||||
| Net Change in LT Investment | EUR mil | ... | ... | ... | ... | 0 | -0.010 | 0 | 13.1 | -10.3 | |||||||||||||
| Net Cash From Acquisitions | EUR mil | ... | ... | ... | ... | ... | ... | ... | 1.26 | -4.78 | 0 | 0 | -31.2 | ||||||||||
| Other Investing Activities | EUR mil | ... | ... | ... | ... | 7.50 | -21.9 | -18.7 | 0 | 0.303 | |||||||||||||
| Total Cash From Investing | EUR mil | ... | ... | ... | ... | -0.858 | -38.6 | -33.4 | -40.3 | -84.3 | |||||||||||||
| Dividends Paid | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Issuance Of Shares | EUR mil | ... | ... | ... | ... | 0 | 0 | 49.1 | 63.4 | 0 | |||||||||||||
| Issuance Of Debt | EUR mil | ... | ... | ... | ... | -1.10 | 72.4 | 55.0 | -12.5 | 224 | |||||||||||||
| Other Financing Activities | EUR mil | ... | ... | ... | ... | -0.322 | -2.22 | 3.97 | 12.4 | 12.2 | |||||||||||||
| Total Cash From Financing | EUR mil | ... | ... | ... | ... | -1.42 | 70.2 | 108 | 63.2 | 236 | |||||||||||||
| Effect of FX Rates | EUR mil | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Net Change In Cash | EUR mil | ... | ... | ... | ... | -27.6 | 13.4 | 38.3 | 27.8 | 157 | |||||||||||||
| ratios | |||||||||||||||||||||||
| Days Sales Outstanding | days | ... | ... | ... | ... | 26.4 | 14.9 | 13.9 | 11.3 | 9.61 | |||||||||||||
| Days Sales Of Inventory | days | ... | ... | ... | ... | 64.5 | 35.9 | 36.7 | 39.6 | 44.4 | |||||||||||||
| Days Payable Outstanding | days | ... | ... | ... | ... | 37.2 | 21.6 | 20.3 | 25.0 | 35.9 | |||||||||||||
| Cash Conversion Cycle | days | ... | ... | ... | ... | 53.7 | 29.2 | 30.3 | 25.9 | 18.1 | |||||||||||||
| Cash Earnings | EUR mil | ... | ... | ... | ... | -18.9 | -30.0 | -21.4 | -10.9 | -62.8 | |||||||||||||
| Free Cash Flow | EUR mil | ... | ... | ... | ... | -26.1 | -56.8 | -69.8 | -35.4 | -79.0 | |||||||||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | 3.39 | 2.20 | 2.10 | 5.51 | 4.07 |
| other ratios | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Employees | ... | ... | ... | ... | 483 | 843 | 1,011 | 1,220 | 1,569 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||||
| Cost Per Employee | USD per month | ... | ... | ... | ... | 3,875 | 4,629 | 5,051 | 5,349 | 7,608 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Cost Per Employee (Local Currency) | EUR per month | ... | ... | ... | ... | 3,451 | 3,952 | 4,457 | 4,571 | 6,354 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Operating Cost (As % of Sales) | % | ... | ... | ... | ... | 28.1 | 23.8 | 24.5 | 22.8 | 31.3 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Research & Development (As % of Sales) | % | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Staff Cost (As % of Sales) | % | ... | ... | ... | ... | 7.04 | 7.41 | 7.71 | 6.91 | 11.3 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||
| Effective Tax Rate | % | ... | ... | ... | ... | 0.210 | 2.84 | 14.0 | -5.27 | 4.75 | |||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 57.7 | 52.6 | 50.5 | 43.0 | |||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Customers | mil | ... | ... | ... | 2.70 | 3.50 | 4.70 | 6.30 | 7.90 |
| valuation | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 670 | 519 | 638 | 3,203 | 2,304 | ||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 642 | 553 | 678 | 3,093 | 2,250 | ||||||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 9.50 | 12.0 | 13.1 | 14.4 | 17.9 | ||||||||||
| Share Price | EUR | ... | ... | ... | ... | ... | ... | ... | 46.4 | 37.6 | 43.5 | 148 | 113 | ||||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | -47.1 | -30.3 | -32.2 | 174 | -48.5 | |||||||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | -20.6 | -13.5 | -15.6 | -127 | -27.3 | |||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | -23.3 | -15.1 | -26.5 | -195 | -32.3 | |||||||||||
| P/FCF | ... | ... | ... | ... | ... | ... | ... | -16.8 | -7.98 | -8.14 | -60.2 | -25.6 | |||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.84 | 2.12 | 2.44 | 5.01 | 4.88 | |||||||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Free Cash Flow Yield | % | ... | ... | ... | ... | ... | ... | ... | -4.38 | -12.8 | -12.4 | -1.29 | -4.11 | ||||||||||
| Earnings Per Share (EPS) | EUR | ... | ... | ... | ... | ... | ... | ... | -2.25 | -2.79 | -2.78 | -1.17 | -4.15 | ||||||||||
| Cash Earnings Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | -1.99 | -2.49 | -1.64 | -0.761 | -3.51 | ||||||||||
| Free Cash Flow Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | -2.75 | -4.71 | -5.35 | -2.46 | -4.42 | ||||||||||
| Book Value Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | 25.2 | 17.8 | 17.8 | 29.6 | 23.2 | ||||||||||
| Dividend Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||
| EV/Sales | ... | ... | ... | ... | ... | ... | ... | 2.01 | 0.875 | 0.854 | 2.73 | 1.77 | |||||||||||
| EV/EBIT | ... | ... | ... | ... | ... | ... | ... | -29.8 | -16.4 | -17.9 | -3,053 | -28.6 | |||||||||||
| EV/Free Cash Flow | ... | ... | ... | ... | ... | ... | ... | -21.9 | -8.32 | -8.57 | -74.7 | -23.8 | |||||||||||
| EV/Capital Employed | ... | ... | ... | ... | ... | ... | ... | 2.23 | 1.90 | 2.25 | 7.39 | 4.99 | |||||||||||
| Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | -26.9 | 24.0 | -0.358 | -57.9 | 255 | |||||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | -32.7 | 25.3 | -34.2 | -53.5 | 361 | |||||||||
| Book Value Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 61.7 | -29.4 | 0.302 | 65.9 | -21.4 | |||||||||
| Market Value per Customer | USD | ... | ... | ... | ... | ... | ... | ... | 248 | 148 | 136 | 508 | 292 | ||||||||||
| Sales per Customer | USD | ... | ... | ... | ... | 118 | 181 | 169 | 180 | 161 | |||||||||||||
| EBITDA per Customer | USD | ... | ... | ... | ... | -5.05 | -5.21 | -4.48 | 2.82 | -5.87 | |||||||||||||
| Net Profit per Customer | USD | ... | ... | ... | ... | -8.88 | -11.2 | -8.75 | -3.11 | -11.2 |
| clients & arpu | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| Customers | mil | ... | ... | ... | 2.70 | 3.50 | 4.70 | 6.30 | 7.90 | ||||||||||||||
| ARPU from Total Business | EUR per month | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| Basket Size (USD) | USD | ... | ... | ... | ... | ... | ... | ... | 64.9 | 85.5 | 75.9 | 77.7 | 73.2 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Repeat Order Rate | % | ... | ... | ... | ... | ... | ... | ... | 76.0 | 81.0 | 82.0 | 82.0 | 82.0 | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Site Visits | mil | ... | ... | ... | ... | ... | ... | ... | 71.5 | 93.1 | 134 | 208 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
By Helgi Library - May 22, 2023
Shop Apotheke Europe made a net profit of EUR -62.6 mil in 2022, up 15.6% compared to the previous year. Historically, between 2013 and 2022, the company's net profit reached a high of EUR -2.83 mil in 2013 and a low of EUR -74.2 mil in 2021. The result i...
By Helgi Library - May 22, 2023
Shop Apotheke Europe made a net profit of EUR -62.6 mil with revenues of EUR 1,229 mil in 2022, up by 15.6% and up by 15.9%, respectively, compared to the previous year. This translates into a net margin of -5.10%. On the operating level, EBITDA reached EUR...
By Helgi Library - May 22, 2023
Shop Apotheke Europe invested a total of EUR 75.0 mil in 2022, up 73.8% compared to the previous year. Historically, between 2016 - 2022, the company's investments stood at a high of EUR 75.0 mil in 2022 and a low of EUR 3.89 mil in 2016. ...
By Helgi Library - May 22, 2023
Shop Apotheke Europe's net debt stood at EUR 92.9 mil and accounted for 26.3% of equity at the end of 2022. The ratio is up 37.7 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 26.3% in 2022 and a l...
By Helgi Library - May 22, 2023
Shop Apotheke Europe stock traded at EUR 41.8 per share at the end 2022 implying a market capitalization of USD 885 mil. Since the end of 2017, stock has appreciated by -9.88% implying an annual average growth of -2.06% In absolute terms, the value of the compan...
By Helgi Library - May 22, 2023
Shop Apotheke Europe stock traded at EUR 41.8 per share at the end 2022 translating into a market capitalization of USD 885 mil. Since the end of 2017, the stock has depreciated by 9.88% representing an annual average growth of -2.06%. At the end of 2022...
By Helgi Library - October 7, 2022
Shop Apotheke Europe made a net profit of EUR -24.8 mil with revenues of EUR 287 mil in 2Q2022, down by 122% and up by 14.7%, respectively, compared to the previous year. This translates into a net margin of -8.64%. On the operating level, EBITDA reached ...
By Helgi Library - October 7, 2022
Shop Apotheke Europe's total assets reached EUR 787 mil at the end of 2Q2022, down 3.67% compared to the previous year. Current assets amounted to EUR 394 mil, or 50.1% of total assets while cash stood at EUR 264 mil at the end of 2Q2022. ...
By Helgi Library - October 7, 2022
Shop Apotheke Europe's operating cash flow stood at EUR -10.9 mil in 2Q2022, down 85.5% when compared to the previous year. Historically, between 4Q2013 - 2Q2022, the firm’s operating cash flow reached a high of EUR 28.2 mil in 1Q2021 and a low of EUR ...
By Helgi Library - May 22, 2023
Shop Apotheke Europe employed 1,569 employees in 2021, up 28.6% compared to the previous year. Historically, between 2013 and 2021, the firm's workforce hit a high of 1,569 employees in 2021 and a low of 133 employees in 2013. Average personnel cost ...
Shop Apotheke Europe NV is a Netherlands-based Company that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company owns and operates online pharmacies in eight European countries such as in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Shop Apotheke Europe has been growing its sales by 13.1% a year on average in the last 5 years. EBITDA has grown on average by 20.5% a year during that time to total of EUR 275 mil in 2030, or 6.72% of sales. That’s compared to 6.05% average margin seen in last five years.
The company netted EUR 152 mil in 2030 implying ROE of 17.7% and ROCE of 15.1%. Again, the average figures were 18.6% and 13.3%, respectively when looking at the previous 5 years.
Shop Apotheke Europe’s net debt amounted to EUR 97.4 mil at the end of 2030, or 10.4% of equity. When compared to EBITDA, net debt was 0.354x, down when compared to average of 1.05x seen in the last 5 years.
Shop Apotheke Europe stock traded at EUR 91.9 per share at the end of 2030 resulting in a market capitalization of USD 1,947 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 6.38x and price to earnings (PE) of 10.9x as of 2030.
Helgi Library 
